Treatment of patients with advanced non-small cell lung cancer
作者： Christophe A Dooms , Johan F Vansteenkiste
DOI: 10.2165/00024669-200403050-00002
关键词:
摘要: In advanced non-small cell lung cancer (NSCLC), an objective response to chemotherapy is of limited value and the impact on survival modest. Therefore, endpoints evaluating patients’ subjective benefit such as symptom control (SC), quality life (QOL) or clinical (CB) have recently been implemented into trials, mostly secondary endpoints.
springer.com
sci-hub.se 参考文章(60)
Gordon C Jayson, Nick Thatcher, Malcolm R Ranson, B Bradley, Heather Anderson, Gemcitabine: symptomatic benefit in advanced non-small cell lung cancer. Seminars in Oncology. ,vol. 24, ,(1997)
R J Gralla, P J Hollen, Comparison of instruments for measuring quality of life in patients with lung cancer Seminars in Oncology. ,vol. 23, pp. 31- 40 ,(1996)
H Anderson, P Hopwood, R J Stephens, N Thatcher, B Cottier, M Nicholson, R Milroy, T S Maughan, S J Falk, M G Bond, P A Burt, C K Connolly, M B McIllmurray, J Carmichael, Gemcitabine plus best supportive care (BSC) vs BSC in inoperable non-small cell lung cancer - a randomized trial with quality of life as the primary outcome British Journal of Cancer. ,vol. 83, pp. 447- 453 ,(2000) , 10.1054/BJOC.2000.1307
C.M. Moinpour, B. Lyons, P.K. Grevstad, L.C. Lovato, J. Crowley, K. Czaplicki, Z.M. Buckner, P.A. Ganz, K. Kelly, D.R. Gandara, Quality of life in advanced non-small-cell lung cancer: results of a Southwest Oncology Group randomized trial Quality of Life Research. ,vol. 11, pp. 115- 126 ,(2002) , 10.1023/A:1015048908822
M. H. Cullen, L. J. Billingham, C. M. Woodroffe, A. D. Chetiyawardana, N. H. Gower, R. Joshi, D. R. Ferry, R. M. Rudd, S. G. Spiro, J. E. Cook, C. Trask, E. Bessell, C. K. Connolly, J. Tobias, R. L. Souhami, Mitomycin, Ifosfamide, and Cisplatin in Unresectable Non–Small-Cell Lung Cancer: Effects on Survival and Quality of Life Journal of Clinical Oncology. ,vol. 17, pp. 3188- 3194 ,(1999) , 10.1200/JCO.1999.17.10.3188
Georg Kemmler, Bernhard Holzner, Martin Kopp, Martina Dünser, Raimund Margreiter, Richard Greil, Barbara Sperner-Unterweger, Comparison of Two Quality-of-Life Instruments for Cancer Patients: The Functional Assessment of Cancer Therapy-General and the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-C30 Journal of Clinical Oncology. ,vol. 17, pp. 2932- 2940 ,(1999) , 10.1200/JCO.1999.17.9.2932
A.B. Sandler, J. Nemunaitis, C. Denham, J. von Pawel, Y. Cormier, U. Gatzemeier, K. Mattson, Ch. Manegold, M.C. Palmer, A. Gregor, B. Nguyen, C. Niyikiza, L.H. Einhorn, Phase III Trial of Gemcitabine Plus Cisplatin Versus Cisplatin Alone in Patients With Locally Advanced or Metastatic Non–Small-Cell Lung Cancer Journal of Clinical Oncology. ,vol. 18, pp. 122- 122 ,(2000) , 10.1200/JCO.2000.18.1.122
Diane Fairclough, David Cella, John Kugler, Eric Rowinsky, Michael Jiroutek, David Johnson, Philip Bonomi, KyungMann Kim, Comparison of Survival and Quality of Life in Advanced Non–Small-Cell Lung Cancer Patients Treated With Two Dose Levels of Paclitaxel Combined With Cisplatin Versus Etoposide With Cisplatin: Results of an Eastern Cooperative Oncology Group Trial Journal of Clinical Oncology. ,vol. 18, pp. 623- 631 ,(2000) , 10.1200/JCO.2000.18.3.623
Ulrich Gatzemeier, Joachim von Pawel, Maya Gottfried, G.P. M. ten Velde, Karin Mattson, Filipo DeMarinis, Peter Harper, Franco Salvati, Gilles Robinet, Antonio Lucenti, Jan Bogaerts, Gilles Gallant, Phase III comparative study of high-dose cisplatin versus a combination of paclitaxel and cisplatin in patients with advanced non-small-cell lung cancer. Journal of Clinical Oncology. ,vol. 18, pp. 3390- 3399 ,(2000) , 10.1200/JCO.2000.18.19.3390
Walter O. Spitzer, Annette J. Dobson, Jane Hall, Esther Chesterman, John Levi, Richard Shepherd, Renaldo N. Battista, Barry R. Catchlove, Measuring the quality of life of cancer patients: a concise QL-index for use by physicians. Journal of Chronic Diseases. ,vol. 34, pp. 585- 597 ,(1981) , 10.1016/0021-9681(81)90058-8